- call +1-201-465-4211
- email sales@mrinsights.biz
Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
And in our report of prostacyclin, the “prostacyclin” means the drugs used for the treatment of pulmonary arterial hypertension.
Scope of the Report:
Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
The global average price of Prostacyclin is in the decreasing trend, from 60.2 USD/Unit in 2013 to 48.4 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
Prostacyclin is widely used for injection, for oral and for inhalation. The most proportion of Prostacyclin is used for oral, and the proportion in 2017 is about 55%. The trend of prostacyclin used for oral is increasing in the following years.
The worldwide market for Prostacyclin is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 2420 million US$ in 2024, from 1760 million US$ in 2019, according to a new study.
This report focuses on the Prostacyclin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Market Segment by Applications, can be divided into
For Injection
For Oral
For Inhalation
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostacyclin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostacyclin, with price, sales, revenue and global market share of Prostacyclin in 2017 and 2018.
Chapter 3, the Prostacyclin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostacyclin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Prostacyclin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Prostacyclin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Prostacyclin Introduction
1.2 Market Analysis by Type
1.2.1 Epoprostenol Sodium
1.2.2 Treprostinil
1.2.3 Iloprost
1.2.4 Beraprost Sodium
1.3 Market Analysis by Applications
1.3.1 For Injection
1.3.2 For Oral
1.3.3 For Inhalation
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 United Therapeutics
2.1.1 Business Overview
2.1.2 Prostacyclin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 United Therapeutics Prostacyclin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Actelion (J & J)
2.2.1 Business Overview
2.2.2 Prostacyclin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Actelion (J & J) Prostacyclin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 GSK
2.3.1 Business Overview
2.3.2 Prostacyclin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Prostacyclin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Teva
2.4.1 Business Overview
2.4.2 Prostacyclin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Prostacyclin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Toray
2.5.1 Business Overview
2.5.2 Prostacyclin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Toray Prostacyclin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Tide Pharma
2.6.1 Business Overview
2.6.2 Prostacyclin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Tide Pharma Prostacyclin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Bayer AG
2.7.1 Business Overview
2.7.2 Prostacyclin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bayer AG Prostacyclin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Prostacyclin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Prostacyclin Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Prostacyclin Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostacyclin Manufacturer Market Share in 2018
3.3.2 Top 6 Prostacyclin Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Prostacyclin Market Analysis by Regions
4.1 Global Prostacyclin Sales, Revenue and Market Share by Regions
4.1.1 Global Prostacyclin Sales and Market Share by Regions (2014-2019)
4.1.2 Global Prostacyclin Revenue and Market Share by Regions (2014-2019)
4.2 North America Prostacyclin Sales and Growth Rate (2014-2019)
4.3 Europe Prostacyclin Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Prostacyclin Sales and Growth Rate (2014-2019)
4.5 South America Prostacyclin Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Prostacyclin Sales and Growth Rate (2014-2019)
5 North America Prostacyclin by Country
5.1 North America Prostacyclin Sales, Revenue and Market Share by Country
5.1.1 North America Prostacyclin Sales and Market Share by Country (2014-2019)
5.1.2 North America Prostacyclin Revenue and Market Share by Country (2014-2019)
5.2 United States Prostacyclin Sales and Growth Rate (2014-2019)
5.3 Canada Prostacyclin Sales and Growth Rate (2014-2019)
5.4 Mexico Prostacyclin Sales and Growth Rate (2014-2019)
6 Europe Prostacyclin by Country
6.1 Europe Prostacyclin Sales, Revenue and Market Share by Country
6.1.1 Europe Prostacyclin Sales and Market Share by Country (2014-2019)
6.1.2 Europe Prostacyclin Revenue and Market Share by Country (2014-2019)
6.2 Germany Prostacyclin Sales and Growth Rate (2014-2019)
6.3 UK Prostacyclin Sales and Growth Rate (2014-2019)
6.4 France Prostacyclin Sales and Growth Rate (2014-2019)
6.5 Russia Prostacyclin Sales and Growth Rate (2014-2019)
6.6 Italy Prostacyclin Sales and Growth Rate (2014-2019)
7 Asia-Pacific Prostacyclin by Country
7.1 Asia-Pacific Prostacyclin Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Prostacyclin Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Prostacyclin Revenue and Market Share by Country (2014-2019)
7.2 China Prostacyclin Sales and Growth Rate (2014-2019)
7.3 Japan Prostacyclin Sales and Growth Rate (2014-2019)
7.4 Korea Prostacyclin Sales and Growth Rate (2014-2019)
7.5 India Prostacyclin Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Prostacyclin Sales and Growth Rate (2014-2019)
8 South America Prostacyclin by Country
8.1 South America Prostacyclin Sales, Revenue and Market Share by Country
8.1.1 South America Prostacyclin Sales and Market Share by Country (2014-2019)
8.1.2 South America Prostacyclin Revenue and Market Share by Country (2014-2019)
8.2 Brazil Prostacyclin Sales and Growth Rate (2014-2019)
8.3 Argentina Prostacyclin Sales and Growth Rate (2014-2019)
8.4 Colombia Prostacyclin Sales and Growth Rate (2014-2019)
9 Middle East and Africa Prostacyclin by Countries
9.1 Middle East and Africa Prostacyclin Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Prostacyclin Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Prostacyclin Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Prostacyclin Sales and Growth Rate (2014-2019)
9.3 Turkey Prostacyclin Sales and Growth Rate (2014-2019)
9.4 Egypt Prostacyclin Sales and Growth Rate (2014-2019)
9.5 Nigeria Prostacyclin Sales and Growth Rate (2014-2019)
9.6 South Africa Prostacyclin Sales and Growth Rate (2014-2019)
10 Global Prostacyclin Market Segment by Type
10.1 Global Prostacyclin Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Prostacyclin Sales and Market Share by Type (2014-2019)
10.1.2 Global Prostacyclin Revenue and Market Share by Type (2014-2019)
10.2 Epoprostenol Sodium Sales Growth and Price
10.2.1 Global Epoprostenol Sodium Sales Growth (2014-2019)
10.2.2 Global Epoprostenol Sodium Price (2014-2019)
10.3 Treprostinil Sales Growth and Price
10.3.1 Global Treprostinil Sales Growth (2014-2019)
10.3.2 Global Treprostinil Price (2014-2019)
10.4 Iloprost Sales Growth and Price
10.4.1 Global Iloprost Sales Growth (2014-2019)
10.4.2 Global Iloprost Price (2014-2019)
10.5 Beraprost Sodium Sales Growth and Price
10.5.1 Global Beraprost Sodium Sales Growth (2014-2019)
10.5.2 Global Beraprost Sodium Price (2014-2019)
11 Global Prostacyclin Market Segment by Application
11.1 Global Prostacyclin Sales Market Share by Application (2014-2019)
11.2 For Injection Sales Growth (2014-2019)
11.3 For Oral Sales Growth (2014-2019)
11.4 For Inhalation Sales Growth (2014-2019)
12 Prostacyclin Market Forecast (2019-2024)
12.1 Global Prostacyclin Sales, Revenue and Growth Rate (2019-2024)
12.2 Prostacyclin Market Forecast by Regions (2019-2024)
12.2.1 North America Prostacyclin Market Forecast (2019-2024)
12.2.2 Europe Prostacyclin Market Forecast (2019-2024)
12.2.3 Asia-Pacific Prostacyclin Market Forecast (2019-2024)
12.2.4 South America Prostacyclin Market Forecast (2019-2024)
12.2.5 Middle East and Africa Prostacyclin Market Forecast (2019-2024)
12.3 Prostacyclin Market Forecast by Type (2019-2024)
12.3.1 Global Prostacyclin Sales Forecast by Type (2019-2024)
12.3.2 Global Prostacyclin Market Share Forecast by Type (2019-2024)
12.4 Prostacyclin Market Forecast by Application (2019-2024)
12.4.1 Global Prostacyclin Sales Forecast by Application (2019-2024)
12.4.2 Global Prostacyclin Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Prostacyclin Picture
Table Product Specifications of Prostacyclin
Figure Global Sales Market Share of Prostacyclin by Types in 2018
Table Prostacyclin T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
